Trial NCT01728181

View at ClinicalTrials.gov 
Org. Study IDs: HCI59004

Last trial update was posted on 2013-07-25

MeSH Interventions

Erlotinib Hydrochloride Tivozanib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

EGFR Unknown or Wild-type Non-small Cell Lung Cancer Stage IV Disease

Stopping Reasons

Stopped before approval due to ineffective drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID